HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Infectious Diseases

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/ciu585PMID 25073894PMCID PMC4200019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune activation and HIV persistence: considerations for novel therapeutic interventions

  2013influential reference
• Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

  2013cited by this paper
• Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

  2013cited by this paper
• A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection

  2013cited by this paper
• HIV pathogenesis: dynamics and genetics of viral populations and infected cells.

  2013cited by this paper
• Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.

  2013cited by this paper
• Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma

  2013cited by this paper
• Cellular and molecular mechanisms involved in the establishment of HIV-1 latency

  2013cited by this paper
• Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.

  2013influential reference
• HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells.

  2013cited by this paper
• HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion

  2013cited by this paper
• Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards

  2012cited by this paper
• No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

  2012cited by this paper
• Redefining the viral reservoirs that prevent HIV-1 eradication.

  2012cited by this paper
• The Role of Innate APOBEC3G and Adaptive AID Immune Responses in HLA-HIV/SIV Immunized SHIV Infected Macaques

  2012cited by this paper
• HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs.

  2012cited by this paper
• Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients

  2012cited by this paper
• A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection

  2012cited by this paper
• An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells

  2012cited by this paper
• Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART

  2011cited by this paper
• Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption

  2011cited by this paper
• Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

  2010cited by this paper
• The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

  2010cited by this paper
• Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

  2010cited by this paper
• HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

  2010cited by this paper
• HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

  2009cited by this paper
• Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS

  2009cited by this paper
• Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

  2009cited by this paper
• Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

  2008cited by this paper
• Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

  2008cited by this paper
• A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load

  2008cited by this paper
• AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT): Rationale, Design, and Baseline Characteristics

  2008cited by this paper
• CD38 expression on CD8 T cells has a weak association with CD4 T‐cell recovery and is a poor marker of viral replication in HIV‐1‐infected patients on antiretroviral therapy

  2008cited by this paper
• ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

  2007cited by this paper
• Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells

  2006cited by this paper
• Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells

  2006cited by this paper
• Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects: Results From ACTG 384

  2006cited by this paper
• Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors

  2006cited by this paper
• In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA

  2005cited by this paper
• New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

  2003cited by this paper
• Identification of two mutually exclusive groups after long-term monitoring of HIV DNA 2-LTR circle copy number in patients on HAART

  2003cited by this paper
• Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication

  2002cited by this paper

• Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes

  2026cites this paper
• Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption

  2025cites this paper
• Association between baseline HIV-1 DNA levels and clinical outcomes in people living with HIV: a meta-analysis of cohort studies

  2025cites this paper
• Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets

  2025cites this paper
• Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy

  2025cites this paper
• The Complex Interactions Between HIV-1 and Human Host Cell Genome: From Molecular Mechanisms to Clinical Practice

  2025cites this paper
• Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/Rilpivirine

  2025cites this paper
• High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection

  2025cites this paper
• Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cells.

  2025cites this paper
• Plasma, Intracellular and Lymph node Antiretroviral Concentrations and HIV DNA Change During Primary HIV Infection: Results from the INACTION P25 Study.

  2024cites this paper
• No evidence for ongoing replication on ART in SIV-infected macaques

  2024cites this paper
• The identification of intact HIV proviral DNA from human cerebrospinal fluid

  2024cites this paper
• Humanized mice for studying HIV latency and potentially its eradication

  2024cites this paper
• HIV vaccination: Navigating the path to a transformative breakthrough—A review of current evidence

  2024cites this paper
• Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir

  2024cites this paper
• The Proviral Reservoirs of Human Immunodeficiency Virus (HIV) Infection

  2024cites this paper
• Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.

  2024cites this paper
• Predictors of HIV rebound differ by timing of antiretroviral therapy initiation

  2024cites this paper
• Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size

  2024cites this paper
• In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA)

  2024cites this paper
• Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapy

  2024cites this paper
• Low-dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals with Chronically Treated HIV-1 Infection

  2024cites this paper
• Machine Learning Bolsters Evidence That D1, Nef, and Tat Influence HIV Reservoir Dynamics

  2024cites this paper
• HIV‐DNA decrease during treatment in primary HIV‐1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial

  2023cites this paper
• Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence

  2023cites this paper
• Impact of misclassified defective proviruses on HIV reservoir measurements

  2023cites this paper
• An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8+ T cell magnitude and short-lived differentiation status

  2023cites this paper
• The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs

  2023cites this paper
• HIV DNA positively correlates with HLA-DR+CD8+ T lymphocytes over 8-year suppressive antiretroviral therapy

  2023cites this paper
• HIV-1–Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities

  2023cites this paper
• Dating reservoir formation in virologically suppressed people living with HIV-1 in Rakai, Uganda

  2023cites this paper
• Epitope-dependent effect of long-term cART on maintenance and recovery of HIV-1-specific CD8+ T cells

  2023cites this paper
• Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir

  2023cites this paper
• Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimen.

  2023cites this paper
• Role of the HIV-1 Reservoir to Maintain Viral Suppression in a Simplified Strategy for the Long-Term Management of HIV-1 Infection (The SIMPL’HIV Trial)

  2022cites this paper
• Subtype C HIV-1 reservoirs throughout the body in ART-suppressed individuals

  2022cites this paper
• Real-world efficacy and safety of dolutegravir plus lamivudine versus tenofovir plus lamivudine and efavirenz in ART-naïve HIV-1-infected adults

  2022cites this paper
• Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

  2022cites this paper
• Accuracy of real-time PCR and digital PCR for the monitoring of total HIV DNA under prolonged antiretroviral therapy

  2022cites this paper
• The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells

  2022cites this paper
• Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment

  2022cites this paper
• Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy

  2022cites this paper
• Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells

  2022cites this paper
• Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot Study

  2021cites this paper
• Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART

  2021cites this paper
• HIV-1 Persistence in Children during Suppressive ART

  2021cites this paper
• Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.

  2021cites this paper
• Intrapatient Development of Multi-Class Drug Resistance in an Individual Infected with HIV-1 CRF01_AE

  2021cites this paper
• Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses Over Time

  2021cites this paper
• Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors

  2021cites this paper
• Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study

  2021cites this paper
• People with HIV-1 Demonstrate Type 1 Interferon Refractoriness Associated with Upregulated USP18

  2021cites this paper
• HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

  2021cites this paper
• Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting

  2021cites this paper
• Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy

  2021cites this paper
• Challenges and Promise of Human Immunodeficiency Virus Remission.

  2021cites this paper
• Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era

  2021cites this paper
• Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy

  2021cites this paper
• Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection

  2021cites this paper
• Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice

  2021cites this paper
• Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen

  2021cites this paper
• Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment.

  2020cites this paper
• HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART

  2020cites this paper
• Persistence of an intact HIV reservoir in phenotypically naive T cells

  2020cites this paper
• Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections

  2020influential citation
• Everolimus, an mTORC1/2 inhibitor, in ART‐suppressed individuals who received solid organ transplantation: A prospective study

  2020cites this paper
• HIV-1 transcription but not intact provirus levels are associated with systemic inflammation.

  2020cites this paper
• Defective HIV-1 proviruses produce viral proteins

  2020cites this paper
• Étude de l’établissement des réservoirs du VIH-1 et de l’impact de l’initiation précoce du traitement sur ces réservoirs chez l’enfant infecté par le VIH-1

  2020cites this paper
• Male sex and obesity are associated with residual plasma HIV-1 viremia in persons on long-term antiretroviral therapy.

  2020cites this paper
• A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication

  2020cites this paper
• Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study

  2020cites this paper
• HIV-1 variants are archived throughout infection and persist in the reservoir

  2020cites this paper
• HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy

  2020cites this paper
• Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv-1 DNA Quantification

  2020cites this paper
• Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.

  2020cites this paper
• Impact of biological sex on immune activation and frequency of the latent HIV reservoir during suppressive antiretroviral therapy.

  2020cites this paper
• Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics

  2020cites this paper
• HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design

  2020cites this paper
• Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials.

  2020cites this paper
• PD-1HI T cells are associated with lower hiv-specific immune responses despite long-term antiretroviral therapy.

  2020cites this paper
• Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

  2020cites this paper
• Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study.

  2020cites this paper
• Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of ART-treated individuals.

  2020cites this paper
• Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy.

  2020cites this paper
• Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART

  2020cites this paper
• CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice

  2020cites this paper
• Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.

  2020cites this paper
• Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy

  2020influential citation
• HIV host genomics in the era of effective antiretroviral therapy

  2020influential citation
• Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy

  2020cites this paper
• Advances toward a cure for HIV: getting beyond n=2.

  2020cites this paper
• 'Rinse and Replace': Boosting T Cell Turnover To Reduce HIV-1 Reservoirs.

  2020cites this paper
• HIV Populations Shift After Tuberculosis Associated Immune Reconstitution Inflammatory Syndrome: Implications For HIV Remission

  2020cites this paper
• The gift of a lifetime: analysis of HIV at autopsy.

  2020cites this paper
• New Frontiers in Measuring and Characterizing the HIV Reservoir

  2019cites this paper
• Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life

  2019cites this paper
• Have Cells Harboring the HIV Reservoir Been Immunoedited?

  2019cites this paper
• HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study

  2019cites this paper
• Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART

  2019cites this paper